Catalog No.
DHF36805
Expression system
Mammalian Cells
Species reactivity
Human
Isotype
Human IgG1 Fc fragment fused to IL2RB disulfide bridged to human IgG1 Fc fragment fused to human IL2
Target
IL2, IL-2, Aldesleukin, Interleukin-2, TCGF, T-cell growth factor, IL-2R subunit beta, Interleukin-15 receptor subunit beta, IL2RB, IL-2 receptor subunit beta, CD122, High affinity IL-2 receptor subunit beta, p75, Interleukin-2 receptor subunit beta, IL-2RB, p70-75, IL15RB
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P60568 & P14784
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
CAS: 2760549-52-6
Clone ID
Efercoleukin Alfa
Rash associated with antibiotic administration in patients with infectious mononucleosis: a systematic review and meta-analysis., PMID:40512251
Integrative Analysis of Drug Co-Prescriptions in Peritoneal Dialysis Reveals Molecular Targets and Novel Strategies for Intervention., PMID:40507495
International Fibrolamellar Cancer Registry: Opportunities and Challenges., PMID:40499052
Rare types of alpha-1-antitrypsin deficency in the same family: Pi*Mmalton and Pi*Plowell., PMID:40497812
Persistent Atelectasis Prevalence and Incidence in Pediatric Critical Care., PMID:40497177
Validation of a handheld electrocardiogram 6 lead recorder to obtain chest lead equivalents: An Africa Heart Rhythm Association study., PMID:40496591
GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours., PMID:40490502
Exploring Antimalarial Activity of Drugs using Weighted Atomic Vectors and Artificial Intelligence., PMID:40485561
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial., PMID:40484014
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data., PMID:40471681
Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose-escalation phase 1 study., PMID:40470753
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A., PMID:40469412
Therapeutic efficacy of budesonide suspension combined with poractant alfa injection for neonatal respiratory distress syndrome and its effect on serum ferritin and PAI-1 expressions., PMID:40469168
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG)., PMID:40450492
The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase Alfa., PMID:40449831
Preclinical Safety., PMID:40445826
Mean Corpuscular Volume Is Not a Reliable Predictor of Iron Deficiency in Patients With Chronic Kidney Disease: A Post-Hoc Analysis of the BRIGHTEN Trial., PMID:40443639
Mobility and Quality of Life in Children with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement., PMID:40439960
Less Invasive Surfactant Administration (LISA) versus Intubation Surfactant Extubation (InSurE) technique using higher volume surfactant in management of neonates with respiratory distress syndrome: an open-label randomized controlled trial., PMID:40439732
Life-Threatening Pharyngolaryngeal Hematoma in a Patient With Hemophilia A., PMID:40438813
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies., PMID:40436467
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial., PMID:40431448
Exploring Multivalent Architectures for Binding and Stabilization of N-Acetylgalactosamine 6-Sulfatase., PMID:40430394
Current status of the immunogenicity of enzyme replacement therapy in fabry disease., PMID:40420145
Phenotypic and Genotypic Spectrum of Indian Patients with Hypophosphatasia., PMID:40416455
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus., PMID:40414777
[Acid sphingomyelinase deficiency: A review]., PMID:40414757
A global comparison of hepatitis B & C drug pricing., PMID:40414600
Fosfomycin for the treatment of patients with bacterial prostatitis: a systematic review., PMID:40410452
Markedly discordant hypophosphatasia in a young girl., PMID:40409424
A Theoretical and Experimental Study of Carbonized Lignin from Alfa Fibers as a Clay-Based Adsorbent., PMID:40402651
Robust longitudinal neuropsychological norms in Spanish individuals with nonpathological Alzheimer's disease biomarkers., PMID:40402619
Development and description of a porcine model of combat casualty care for traumatic-hemorrhagic shock research and medical training., PMID:40402209
Reversal of anticoagulation in patients with intracerebral haemorrhage related to oral anticoagulants: State of the evidence., PMID:40401655
Effects of erythropoietin on cardiac morphometry in exercised male and female adolescent rats., PMID:40400735
Good clinical practice recommendations for the diagnosis and treatment of functional dyspepsia: An expert review from the Asociación Mexicana de Gastroenterología., PMID:40399175
Defining clinically meaningful thresholds for forced vital capacity in patients with neuromuscular disorders: Lessons learned from the COMET study in Pompe disease., PMID:40397025
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer, a study with 5-year follow-up: a plain language summary., PMID:40396643
Case of Gynandroblastoma of the Ovary with Raised AFP and Associated DICER 1 Mutation., PMID:40390890
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study., PMID:40390028
SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper., PMID:40388563
Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach., PMID:40384539
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial., PMID:40384092
Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids., PMID:40383704
Venous thromboembolism in professional drivers of automatic transmission vehicles: an underestimated occupational risk?, PMID:40382788
Author's reply: "Comment on "Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases""., PMID:40379540
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial., PMID:40377899
Correction: Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera., PMID:40377864
HBV-specific T-cell function is nonenhanced by tenofovir-induced decline in HBV viremia or HBsAg titer in chronic hepatitis B., PMID:40377525
Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis., PMID:40377239
For research use only. Not for human or drug use.
